Somnomed Ltd (SOM) - Total Liabilities

Latest as of December 2025: AU$29.86 Million AUD ≈ $21.13 Million USD

Based on the latest financial reports, Somnomed Ltd (SOM) has total liabilities worth AU$29.86 Million AUD (≈ $21.13 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Somnomed Ltd - Total Liabilities Trend (2003–2025)

This chart illustrates how Somnomed Ltd's total liabilities have evolved over time, based on quarterly financial data. See Somnomed Ltd (SOM) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Somnomed Ltd Competitors by Total Liabilities

The table below lists competitors of Somnomed Ltd ranked by their total liabilities.

Company Country Total Liabilities
Swift Haulage Bhd
KLSE:5303
Malaysia RM990.35 Million
Aesler Grup Internasional Tbk Pt
JK:RONY
Indonesia Rp24.40 Billion
CX Technology Corp
TW:2415
Taiwan NT$6.81 Billion
Kumpulan Kitacon Berhad
KLSE:5310
Malaysia RM430.69 Million
Chunghwa Chemical Synthesis & Biotech Co Ltd
TW:1762
Taiwan NT$1.28 Billion
Alcadon Group AB
ST:ALCA
Sweden Skr737.80 Million
Cosmax Nbt Inc
KQ:222040
Korea ₩242.96 Billion
Codes Combine Co. Ltd
KQ:047770
Korea ₩23.36 Billion

Liability Composition Analysis (2003–2025)

This chart breaks down Somnomed Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see SOM stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.76 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.60 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.37 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Somnomed Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Somnomed Ltd (2003–2025)

The table below shows the annual total liabilities of Somnomed Ltd from 2003 to 2025.

Year Total Liabilities Change
2025-06-30 AU$34.58 Million
≈ $24.47 Million
+39.55%
2024-06-30 AU$24.78 Million
≈ $17.53 Million
-38.18%
2023-06-30 AU$40.09 Million
≈ $28.36 Million
+32.28%
2022-06-30 AU$30.31 Million
≈ $21.44 Million
+26.23%
2021-06-30 AU$24.01 Million
≈ $16.99 Million
-13.82%
2020-06-30 AU$27.86 Million
≈ $19.71 Million
+64.54%
2019-06-30 AU$16.93 Million
≈ $11.98 Million
+30.95%
2018-06-30 AU$12.93 Million
≈ $9.15 Million
+26.05%
2017-06-30 AU$10.26 Million
≈ $7.26 Million
+32.55%
2016-06-30 AU$7.74 Million
≈ $5.48 Million
+23.96%
2015-06-30 AU$6.24 Million
≈ $4.42 Million
-5.03%
2014-06-30 AU$6.57 Million
≈ $4.65 Million
-2.32%
2013-06-30 AU$6.73 Million
≈ $4.76 Million
+98.40%
2012-06-30 AU$3.39 Million
≈ $2.40 Million
+34.87%
2011-06-30 AU$2.51 Million
≈ $1.78 Million
+15.19%
2010-06-30 AU$2.18 Million
≈ $1.54 Million
+28.06%
2009-06-30 AU$1.70 Million
≈ $1.21 Million
+71.21%
2008-06-30 AU$995.73K
≈ $704.54K
+26.76%
2007-06-30 AU$785.50K
≈ $555.79K
-5.90%
2006-06-30 AU$834.72K
≈ $590.62K
+16.53%
2005-06-30 AU$716.30K
≈ $506.83K
-8.73%
2004-06-30 AU$784.78K
≈ $555.28K
+26059.43%
2003-06-30 AU$3.00K
≈ $2.12K
--

About Somnomed Ltd

AU:SOM Australia Medical Devices
Market Cap
$86.03 Million
AU$121.59 Million AUD
Market Cap Rank
#19836 Global
#652 in Australia
Share Price
AU$0.56
Change (1 day)
+0.91%
52-Week Range
AU$0.53 - AU$0.89
All Time High
AU$3.28
About

SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe. It provides SomnoDent Avant, as well as SomnoDent Classic, SomnoDent Flex, and SomnoDent Fusion are offered for the treatment of obstructive sleep apnea. The company also offers SomMorning Repositioner, a product desig… Read more